Fact.MR's global chemotherapy-induced nausea and vomiting (CINV) treatment industry analysis predicts the market to attain a valuation of US$ 5.7 Bn by the end of the decade, which will be 1.5X its worth at present. This research survey forecasts the market to expand at a significant CAGR of around 6% through 2031, with the U.S. slated to account for over 85% market share in North America....
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian